Plasma Glycated CD59 Predicts Early Gestational Diabetes and Large for Gestational Age Newborns

CONTEXT: Gestational diabetes mellitus (GDM) diagnosed in early pregnancy is a health care challenge because it increases the risk of adverse outcomes. Plasma-glycated CD59 (pGCD59) is an emerging biomarker for diabetes and GDM. The aim of this study was to assess the performance of pGCD59 as a biom...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Endocrinol Metab
Hlavní autoři: Ma, DongDong, Luque-Fernandez, Miguel Angel, Bogdanet, Delia, Desoye, Gernot, Dunne, Fidelma, Halperin, Jose A
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2020
Témata:
Clinical Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7082084/
https://ncbi.nlm.nih.gov/pubmed/32069353
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/clinem/dgaa087
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky